The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitroXian Chen, Xuechi Lin|International Journal of Molecular Medicine|2017Cited by 95
Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathminFang Shen, Xuechi Lin|Oncology Reports|2017Cited by 35
Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein�18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cellsSangyan Chen, Xuechi Lin|Oncology Reports|2019Cited by 29